194 related articles for article (PubMed ID: 9327526)
1. Priming of T cells by heat shock protein-peptide complexes as the basis of tumor vaccines.
Li Z
Semin Immunol; 1997 Oct; 9(5):315-22. PubMed ID: 9327526
[TBL] [Abstract][Full Text] [Related]
2. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
3. [Role of heat shock protein-peptide complexes on tumor and infectious diseases immunity].
Meng SD; Gao F; Tien P
Sheng Wu Gong Cheng Xue Bao; 2000 Jul; 16(4):425-8. PubMed ID: 11051811
[TBL] [Abstract][Full Text] [Related]
4. Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70.
Robert J; Ménoret A; Basu S; Cohen N; Srivastava PR
Eur J Immunol; 2001 Jan; 31(1):186-95. PubMed ID: 11265634
[TBL] [Abstract][Full Text] [Related]
5. Heat shock proteins: to present or not, that is the question.
Gullo CA; Teoh G
Immunol Lett; 2004 Jun; 94(1-2):1-10. PubMed ID: 15234529
[TBL] [Abstract][Full Text] [Related]
6. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens.
Srivastava PK
Methods; 1997 Jun; 12(2):165-71. PubMed ID: 9184380
[TBL] [Abstract][Full Text] [Related]
7. Heat-shock protein-based anticancer immunotherapy: an idea whose time has come.
Ménoret A; Chandawarkar R
Semin Oncol; 1998 Dec; 25(6):654-60. PubMed ID: 9865680
[TBL] [Abstract][Full Text] [Related]
8. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
[TBL] [Abstract][Full Text] [Related]
9. Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.
Bleifuss E; Bendz H; Sirch B; Thompson S; Brandl A; Milani V; Graner MW; Drexler I; Kuppner M; Katsanis E; Noessner E; Issels RD
Int J Hyperthermia; 2008 Dec; 24(8):623-37. PubMed ID: 18608582
[TBL] [Abstract][Full Text] [Related]
10. Heat shock proteins gp96 as immunogens in cancer patients.
Parmiani G; De Filippo A; Pilla L; Castelli C; Rivoltini L
Int J Hyperthermia; 2006 May; 22(3):223-7. PubMed ID: 16754342
[TBL] [Abstract][Full Text] [Related]
11. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
[TBL] [Abstract][Full Text] [Related]
12. Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation.
Murshid A; Gong J; Calderwood SK
Expert Rev Vaccines; 2008 Sep; 7(7):1019-30. PubMed ID: 18767951
[TBL] [Abstract][Full Text] [Related]
13. A broadly applicable, personalized heat shock protein-mediated oncolytic tumor vaccine.
Huang XF; Ren W; Rollins L; Pittman P; Shah M; Shen L; Gu Q; Strube R; Hu F; Chen SY
Cancer Res; 2003 Nov; 63(21):7321-9. PubMed ID: 14612530
[TBL] [Abstract][Full Text] [Related]
14. Genetically modified tumour vaccines--where we are today.
Nawrocki S; Mackiewicz A
Cancer Treat Rev; 1999 Feb; 25(1):29-46. PubMed ID: 10212588
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein-peptide complex in the treatment of glioblastoma.
See AP; Pradilla G; Yang I; Han S; Parsa AT; Lim M
Expert Rev Vaccines; 2011 Jun; 10(6):721-31. PubMed ID: 21692695
[TBL] [Abstract][Full Text] [Related]
16. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
17. Secreted heat shock protein gp96-Ig: an innovative vaccine approach.
Strbo N; Podack ER
Am J Reprod Immunol; 2008 May; 59(5):407-16. PubMed ID: 18405311
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein vaccines: from bench to bedside.
Binder RJ
Int Rev Immunol; 2006; 25(5-6):353-75. PubMed ID: 17169780
[TBL] [Abstract][Full Text] [Related]
19. [Heat shock proteins, immune competence and vaccination].
Milani V; Endres M; Kuppner MC; Issels RD; Noessner E
Dtsch Med Wochenschr; 2004 Jan; 129(1-2):31-5. PubMed ID: 14703579
[No Abstract] [Full Text] [Related]
20. Immunostimulatory functions of membrane-bound and exported heat shock protein 70.
Radons J; Multhoff G
Exerc Immunol Rev; 2005; 11():17-33. PubMed ID: 16385841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
